BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37063925)

  • 1. Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses.
    Rodríguez-Pulido M; Calvo-Pinilla E; Polo M; Saiz JC; Fernández-González R; Pericuesta E; Gutiérrez-Adán A; Sobrino F; Martín-Acebes MA; Sáiz M
    Front Immunol; 2023; 14():1166725. PubMed ID: 37063925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic RNA derived from the foot-and-mouth disease virus genome elicits antiviral responses in bovine and porcine cells through IRF3 activation.
    Rodríguez Pulido M; Del Amo L; Sobrino F; Sáiz M
    Vet Microbiol; 2018 Jul; 221():8-12. PubMed ID: 29981712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation.
    Borrego B; Rodríguez-Pulido M; Revilla C; Álvarez B; Sobrino F; Domínguez J; Sáiz M
    Viruses; 2015 Jul; 7(7):3954-73. PubMed ID: 26193305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice.
    Rodríguez-Pulido M; Borrego B; Sobrino F; Sáiz M
    J Virol; 2011 Jul; 85(13):6492-501. PubMed ID: 21525336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Wide-Ranging Antiviral Response in Wild Boar Cells Is Triggered by Non-coding Synthetic RNAs From the Foot-and-Mouth Disease Virus Genome.
    Rodríguez Pulido M; H B R; Sáiz M
    Front Vet Sci; 2020; 7():495. PubMed ID: 32851049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
    Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
    J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Foot-and-Mouth Disease Virus Non-coding Synthetic RNAs as Vaccine Adjuvants.
    Rodríguez-Pulido M; Polo M; Borrego B; Sáiz M
    Methods Mol Biol; 2022; 2465():125-135. PubMed ID: 35118619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations.
    Zhai X; Wang N; Jiao H; Zhang J; Li C; Ren W; Reiter RJ; Su S
    J Pineal Res; 2021 Sep; 71(2):e12754. PubMed ID: 34139040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
    Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
    Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
    Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of the DeISGylation Activity of Foot-and-Mouth Disease Virus Lpro Causes Attenuation
    Medina GN; Azzinaro P; Ramirez-Medina E; Gutkoska J; Fang Y; Diaz-San Segundo F; de Los Santos T
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
    Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
    Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection.
    Rodríguez-Pulido M; Sobrino F; Borrego B; Sáiz M
    Antiviral Res; 2011 Dec; 92(3):500-4. PubMed ID: 22020303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.